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the plot of raw output versus pulses at least one day prior to the 
failure. 
Conclusions: Energy variations of Tomo HD can be monitored by Exit 
Detector Flatness in the TQA software. Abnormal waveforms from raw 
output can be observed before a magnetron failure in more than half 
of the cases. 
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Purpose/Objective: 3D dose and dose volume histogram (dvh) 
calculation is a new option of the delta 4 phantom for pre-treatment 
verification; dose deviation can be rated differently depending on 
where it occurs: in a target, in an organ at risk or in a non critical 
structure. For example an under dosage in an organ at risk should not 
trigger a fail-indication whereas a similar under dosage in a target 
definitely should trigger a fail indication. The purpose of this study is 
to evaluate the Dose volume histrograms of 250 patients measured 
with Delta 4 diode array Phantom (Scandidos), grouped per pathology 
and tumor site and to find some new acceptance criteria based on 
clinical significance. 
Materials and Methods: 250 patients were treated using VMAT arc 
delivery for various tumor sites; all treatments were planned with 
Elekta Monaco planning system (ver. 3.2) and delivered on an Elekta 
Synergy (40x40 cm2field size without interdigitation) or on an Elekta 
Axesse (21x16 cm2field size with 0.4 cm leaves with full 
interdigitation). Each treatment plan was then measured using Delta 4 
diode array cylindrical phantom. First all measurements were 
compared to the treatment planning system dose distribution via 
gamma analysis (3 % dose difference , 3 mm distance to agreement 
criteria) .The presence of the carbon fiber couch was taken into 
account. The software of the Delta 4 defines ROI inside the phantom 
that are identical to the imported patient structures regarding shape 
and position towards the isocenter, therefore dvhs where calculated 
inside the cylindrical homogenous phantom for planned and measured 
3D dose distribution. The patients were divided into nine groups 
according to tumor site (anus , head&neck, snc, liver, lung, lung 
sbrt,rectum, prostate, mediastinum) and, for each site, the most 
critical organs at risk were selected. We compared dvhs parameters 
such as V95% and V107% for PTV, D1 for spinal cord , median dose for 
parotids and so on for the dose calculated and measured. 
Results: In the table is shown the result of the gamma analysis for all 
patients.If Γ(3mm, 3%) = 90% is a reasonable cutoff for accepting the 
plan , we found 14% of the patients having a gamma value less then 
acceptance criteria. Performing the dvhs analysis for these patients, 
comparing calculated and measured parameters, we found a 
discrepancy between values of the most critical organ at risk more 
than 5% only in 4% of the all patients; for these patients, we have 
definitively rejected the plan. 
 
 
 
 
 
Conclusions: One of the main benefits in making pre-treatment 
verification based on 3D and dvhs data is that acceptance criteria 
might be based on clinica lsignificance: you can evaluate if the 
discrepancy between measured and planned dose is in a critical organ 
or if it is in the healthy tissue. We propose aselection criteria based 
on the evaluation of the gamma index of the dosedistribtion and the % 
difference of the constraints between calculated and measured plan. 
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Purpose/Objective: The investigation was performed in order to 
compare radiotherapy dose distributions in tissues surrounding the 
titanium or resorbable implants used clinically for joining and 
consolidating of the facial bones. Inhomogeneous dose distributions 
can be a reason of the normal tissue complications observed during 
the radiotherapy of patients after surgery during which the titanium 
plates were implanted. The knowledge about the distribution of the 
dose around the implants would help to decide whether to preserve or 
to remove the implants before irradiation. 
Materials and Methods: The commonly available resorbable implants 
require comparing them with the titanium implants in case of patients 
requiring radiotherapy after surgery. The dose distributions around 
the titanium and around the resorbable implants were measured and 
compared. Nucletron Oncentra MasterPlan treatment planning system 
(TPS) was used for the calculation of the dose distributions. For 
measurements, Gafchromic EBT radiochromic dosimetry films were 
used for recording the dose distributions in tissue equivalent 
phantoms. The phantoms and films were irradiated with 4 MV photon 
beams of Varian Clinac 600C/D linear accelerator.The irradiated films 
were digitized with Epson 10000XL flat bed scanner and the dose 
distributions were compared using 3Cognition FilmQA software. 
Results: The dose measured on the contact surfaces between the 
titanium implant and the phantom material proximal and distal to the 
beam source at depth of 2.5 cm were 109% and 92% of the reference 
dose measured in homogenous tissues without the implants, 
respectively. For the resorbable implants the doses measured on the 
proximal and the distal contact surfaces were 102% and 101% of the 
reference dose respectively. An interaction of ionization radiation 
with the titanium reconstruction plates is widely discussed in the 
literature. The distortions of the homogenous dose distribution around 
the implants appear only at the distance of few millimeters, but this 
is often more than the thickness of the normal tissue or even the 
tumor in that localization. Clinically, the risk of complications should 
be regarded in form of early or late complications or recurrent 
tumors. 
Conclusions: The titanium plates significantly affect the homogeneity 
of the dose distribution and create the underdose and overdose 
regions. Apart of these effects the presence of the titanium implants 
during the computer tomography examination creates the image 
artifacts which may significantly disturb the target volume delineation 
as well as the early detection of the recurrent cancer in the cavities 
after surgery. The resorbable implants affect the homogeneity of dose 
distributions in significantly lesser degree in the irradiated media and 
their presence does not generate the image artifacts during CT 
examinations.  
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Purpose/Objective: At the moment it is recommended to perform an 
independent check of the MUs calculated by the treatment planning 
system (TPS). In modern complex treatment techniques it is not 
feasible to perform these checks by hand, Diamond (PTW Freiburg) is 
a secondary check software that allows independent MU and point 
dose verification for conformal and IMRT treatment plans which 
validation has been already reported in the literature. The purpose of 
this work is to describe the practical aspects and results in our 
experience in using Diamond for RapidArc (RA) treatments. 
Materials and Methods: Our department has been recently equipped 
with 3 Varian linacs (with RA) and 6 Eclipse (10.0) TPS stations that 
are used to calculate dose distributions. As a part of our QC program 
all the dose calculations are independently checked, in particular our 
IMRT pre-treatment protocol establishes that prior to each treatment, 
calculations are verified at least with Diamond software (PTW), Portal 
Dosimetry (Varian) and Octavius4D (PTW). For the MU/point dose 
verification Dicom files exported from Eclipse (dose, plan and 
structure) are imported by Diamond which compares results against 
the TPS. The isocenter coordinates and dose are automatically read by 
Diamond to perform the comparison, but if it is not a representative 
dose point for all the arcs, extra points must be generated in Eclipse 
and manually introduced in Diamond. We have analyzed the results of 
the comparisons as well the practical questions that have arisen. 
Results: More than 700 plans have been calculated since February 
2012, being about 45% RA treatments. Several arcs are commonly used 
(1-4), 2 for the majority of the plans (65%). The average obtained 
deviation has been 0.29%, being the maximum found deviation of 8% 
in a point. The verification takes about 15 minutes to be performed 
including the time needed to introduce the extra dose points that are 
not read by Diamond. The main practical drawbacks that we have 
faced are: the program automatically reads the structures file in order 
to take into account the patient contour and consequently the depth 
at each control point of the arc, but when the external contour 
 DTA Γ 3% 3mm Γ 5% 3mm
mean 96.6 93.8 97.14 
Dev st 7 7 4.7 
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defined at the TPS includes the fixation system, the program 
calculates the whole path as tissue; although for conformal 
radiotherapy heterogeneity contours can be drawn in the BEV, there is 
no way in doing the same in the calculation slice as it would be 
necessary for treatments involving large areas with low or high 
densities as lung treatments; large couch rotations are not addressed 
by the system. 
Conclusions: Diamond has proven to be an efficient tool to perform 
independent verifications of TPS calculations. From our initial 
experience we have found that some minor changes in the program 
such as an improvement in the introduction of all the desired 
calculation points or the possibility of modification of the calculation 
slice (removing support structures, adding heterogeneities) would be 
very helpful to users.  
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Purpose/Objective: The use of Volumetric Modulated Arc Therapy 
(VMAT) treatment plans for radiotherapy treatments of head and neck 
patients is increasing mainly due to shorter treatment times compared 
to IMRT. However, accurate multileaf collimator (MLC) leaf positioning 
plays an essential role in the effective implementation of VMAT. The 
aim for the present work is to investigate the sensitivity of a new 
patient specific QA-measurement system for QA during treatments 
with respect to MLC leaf positioning errors.  
Materials and Methods: Ten head and neck patients previously 
planned and treated with a VMAT technique were used in the study. 
The original plans were exported and the leaf positions were changed 
to simulate five different systematic positioning errors of the MLC-
banks. That is + 0.2 mm and + 0.5 mm of all leaf positions in each leaf 
bank (X1 and X2). Negative and positive errors make the leaf end-to-
end distance smaller and larger, respectively. The fifth plan simulated 
a random error of each leaf in each control point with a standard 
deviation of 0.5 mm. After the MLC leaf positioning errors were 
introduced the plans were re-imported and re-calculated in the 
treatment planning system. Measurements, with a Delta4PT and a 
Delta4AT system, for the modified plans, were compared with 
calculated doses of the original plans and with each other. The 
agreement between calculation and measurement was evaluated using 
gamma index with 3%/3 mm and 3%/2 mm criteria.  
Results: Comparing the original treatment plans with the plans 
representing MLC leaf positioning errors show that the target coverage 
decreases significantly for + 0.5 mm leaf position errors and the dose 
to the organs at risk increases significantly. The sensitivity of the 
upstream detector system was large for all plans with clinical relevant 
MLC leaf positioning errors.  
Conclusions: The capability of detecting clinical relevant leaf 
positioning errors with the upstream detector system was good.  
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Purpose/Objective: After certain types of brain surgery part of the 
skull bone may require to be replaced by a titanium plate. If such 
patients have a tumour recurrence Gamma Knife treatment may be 
required. The effects of a 0.5mm titanium plate on dosimetry were 
investigated. 
Materials and Methods: On a Gamma KnifePerfexion the spherical ABS 
phantom was used to measure dose with and without thetitanium 
plate (superior, one 16mm shot) and with titanium plate only within 
halfthe field. EBT 2 film was exposed directlyunder the plate and in a 
plane in 1cm wax. to 5Gy. Transmission from a single sector was 
measured with a 0.125cc ion chamber (PTW 31010). The central slab 
from the ABS phantom was placed on a Perspex block of 15x15x20cm3 
in order to position the chamber centre 5mm beneath the plate 
surface. Chamber,holder and phantom where fixed on the eXtend 
system and a CT scan performed. This arrangement was irradiated 
with 2 Gy to the 100% isodose from a single 16mm sector to the centre 
of the ion chamber as scanned(no absorber material), with the 
titanium plate directly in contact with the phantom surface, and with 
1cm air gap Thetransmission of the titanium plate was also measured 
on a 6MV Linac with a10x10 and a 4x4cm field and SSD 100cm with a 
Farmer type chamber in 5cm water and on a orthovoltage unit with 
220kV (6x6cm, FSD 53cm).  
Results: On film only a dose increase of a few percent directly under 
the plate was measureable with the film scanner. No difference was 
observed on the film at 1cm depth between irradiation with or 
without the titanium plate and no difference observed for the half 
covered area. Single sector measured transmission with the ion 
chamber showed an absorption of 0.7% when a1cm gap of air was left 
between titanium plate and the surface. A dose increase of 0.4% was 
measured when the titanium plate was placed directly in contact to 
the slab of the chamber holder. On the 6MV Linac the absorption of 
the titanium plate was 0.6% and 0.8% for the 10x10 respectively 
4x4cm field respectively. On the 220kV X-ray unit an absorption of 
5.4% was measured for the 0.5mm titanium plate. 
Conclusions: Absorption due to the Titanium plate used for skull bone 
replacement seems to be minimal for Cobalt-60 energy. The dose 
increase directly after the titanium plate is measureable but due to 
the multi circular beam arrangement of the Gamma Knife the effect is 
spread. Special care should be given to targets with a distance of less 
than 3mm to the titanium implant due to the dose increase when all 
beams intersect at the same place.  
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Purpose/Objective: The demand for safety and quality assurance in 
RT is becoming increasingly urgent. This is a need felt by professionals 
involved, caused by the growing complexity of RT techniques and 
technologies involved in treatment delivery, as well as by patients, 
because of the increasing attention paid by non- specialist press to RT 
accidents. As an associate member of a National Project financed by 
the National Institute of Nuclear Physics, aiming to development of in 
vivo dosimetry (IVD) procedures for RT, our Institution have 
participated in testing the IVD procedure and software, specific for 
3DCRT. Here we propose the preliminary results of a trial aiming to 
IVD integration in quality management of pelvic RT. 
Materials and Methods: 15 consecutive patients undergone to 3DCRT 
for pelvic cancer (prostate, rectum or gynecologic tumors) were 
selected. A personalized 3DCRT treatment plan was prepared for all of 
them, consisting of a set of 4 or 5 MLC conformed beams (open or 
wedged beams), with an isocentric prescription dose/fraction of 1.8 
Gy, (number of fractions ranging between 25 and 43). DRRs of a 
couple of square orthogonal isocentric fields were also obtained for 
patient setup verification on linac couch. Geometric and dosimetric 
plan data were then transferred to the R&V Network, to make them 
allowable to both linac interface and IVD software. An integrated 
approach, based on scheduled setup verifications (SVs) and IVD checks 
has been tested for each selected patient during the course of RT, 
consisting of: i) a comparison between the EPID images of the couple 
of orthogonal beams and the corresponding DRRs before treatment 
delivery and ii) the calculation for each field of R ratio between the 
TPS calculated isocentric dose and the delivered dose during the 
treatment session.  
Results: As SVs and IVD checks were scheduled on different treatment 
days, total amount of time required for tests during a treatment 
session resulted compatible with staff workload. 
For all tested patients SVs showed average deviations equal to 2.9 
mm, with every single value below the action level (±4 mm), 
confirming a day by day setup reproducibility inside quality standard. 
A total of 176 IVD tests were performed on 44 different sessions. In 
84% of the IVD checks the results were within the accepted tolerance 
of 5% for R. In the 16% of cases, 1 or more R values resulted out of 
tolerance. The average R value on each of the 44 sessions resulted 
within tolerance range in 93% of cases. A more detailed analysis of 
unsuccessful tests revealed the following causes for dose discrepancy: 
presence of gas pockets, attenuating media on beam axis at beam 
exit, random loss of patient setup during treatment.  
Conclusions: An integrated approach based on SVs and an IVD tests 
can be a valuable tool in quality management of pelvic 3DCRT: in case 
of discrepancy between delivered and planned doses, IVD gives to RT 
team the chance to analyze and program adequate corrections in 
further RT sessions. 
   
 
 
 
